Furthermore, as studies have shown that AMPK exerts opposite effects on the central nervous system and peripheral metabolism, activation of the system is not the best strategy to treat obesity, so site-specific operations on AMPK are necessary. The gene discussed is PRKAA1; the disease is Obesity.